FDA advisory committee for peptides stocked with conflicts of interest

The FDA has listed its advisory members for the committee that will discuss peptides in late July. Owais Durrani, DO, an emergency medicine physician in Houston, previously wrote for Healio that “some of the most transformative drugs in modern medicine are peptides,” including insulin and semaglutide. While “the science of peptides is real, serious and worth

mercoledì 1 luglio 2026 New tab

July 01, 2026

4 min read

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

FDA advisory committee for peptides stocked with conflicts of interest

FDA advisory committee for peptides stocked with conflicts of interest

Other newsrooms on this story

Related reading

Longevity, wellness physicians named to panel advising FDA on peptides

FDA reviewers oppose allowing seven peptides for compounding

FDA Panel on Peptides Will Include Experts Who Promote the Unproven Chemicals

RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access

FDA panel on peptides will include experts who promote the unproven chemicals…

FDA panel on peptides will include experts who promote the unproven chemicals…

Other newsrooms on this story

Related reading

Longevity, wellness physicians named to panel advising FDA on peptides

FDA reviewers oppose allowing seven peptides for compounding

FDA Panel on Peptides Will Include Experts Who Promote the Unproven Chemicals

RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access

FDA panel on peptides will include experts who promote the unproven chemicals…

FDA panel on peptides will include experts who promote the unproven chemicals…